Wednesday, April 02, 2014 10:41:00 AM
1) Brean wining/dining IPCI for future business.
2) Strategic advice RE: how to grow the company, i.e., should we license out all of our generic drugs and just become a "royalty" company OR should we raise capital to do our own manufacturing and marketing OR a combination of the above. IPCI at a crossroads, as ANDAs are starting to get approved.
3) A partnership proposal is on the table (Rexista?); IPCI seeking investment banking advice as to whether partnership is reasonable.
4) A buyout offer was proposed, and again IPCI seeking advice.
If I had to lay money, it would be 1 or 2, but we also know IPCI is seeking an appropriate partner for Rexista.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM